Show simple item record

dc.identifier.urihttp://hdl.handle.net/11401/76488
dc.description.sponsorshipThis work is sponsored by the Stony Brook University Graduate School in compliance with the requirements for completion of degree.en_US
dc.formatMonograph
dc.format.mediumElectronic Resourceen_US
dc.language.isoen_US
dc.publisherThe Graduate School, Stony Brook University: Stony Brook, NY.
dc.typeDissertation
dcterms.abstractThe functional loss of PTEN through mutations, deletions, or protein degradation has been found at a high frequency in many human cancers. Therefore, the Pten gene locus has been targeted to generate clinically relevant mouse models for metastatic prostate cancer. The first two chapters include the development and exploration of RapidCaP, a novel mouse model for prostate cancer metastasis, that is based on surgical gene transfer to overcome the need for extensive animal breeding. Through prostate specific delivery of transgenic virus, model generation times have been reduced from several years to a few weeks. Moreover, non-invasive Xenogen-based imaging can be used to monitor disease progression. Using RapidCaP, it is shown that focal loss of Pten and Trp53 genes in prostate triggers distant metastasis at 56% penetrance by 4 months. Molecular pathology analysis revealed spontaneous Myc activation in metastatic nodules. Importantly, it was confirmed that Myc can induce local metastasis using a Myc-transgenic RapidCaP model. This demonstrates the identification and functional validation of the system. In castration therapy trials, both primary and metastatic disease respond with regression, but later relapse to produce lethal, castration resistant disease, as seen in human. The RapidCaP system thus introduces a fast and faithful platform for research and therapy of metastatic prostate cancer in genetically engineered mice. The last chapter presents the generation of a dual color reporter system for identification of the regulators of PTEN stability. Taken together, this thesis introduces novel tools for cancer discovery and their application for understanding prostate metastasis.
dcterms.available2017-09-20T16:50:24Z
dcterms.contributorMills, Aleaen_US
dcterms.contributorTrotman, Lloyd Cen_US
dcterms.contributorJoshua-Tor, Leemoren_US
dcterms.contributorVakoc, Christopheren_US
dcterms.contributorLowe, Scott.en_US
dcterms.creatorCho, Hyejin
dcterms.dateAccepted2017-09-20T16:50:24Z
dcterms.dateSubmitted2017-09-20T16:50:24Z
dcterms.descriptionDepartment of Molecular and Cellular Biology.en_US
dcterms.extent143 pg.en_US
dcterms.formatMonograph
dcterms.formatApplication/PDFen_US
dcterms.identifierhttp://hdl.handle.net/11401/76488
dcterms.issued2015-08-01
dcterms.languageen_US
dcterms.provenanceMade available in DSpace on 2017-09-20T16:50:24Z (GMT). No. of bitstreams: 1 Cho_grad.sunysb_0771E_11457.pdf: 10322198 bytes, checksum: 51c7e51d13e19c35e3e4cae002a99ab7 (MD5) Previous issue date: 2013en
dcterms.publisherThe Graduate School, Stony Brook University: Stony Brook, NY.
dcterms.subjectMolecular biology
dcterms.subjectCastration, Metastasis, Prostate, PTEN, RapidCaP, Therapy
dcterms.titleRapidCaP, a mouse model for analysis and therapy of prostate cancer reveals drivers of Pten-mutant metastasis.
dcterms.typeDissertation


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record